Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Vyloy (zolbetuximab-clzb) for the Treatment of Advanced Gastric and GEJ Cancer
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved...
FDA Approves Vyalev (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease
AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved Vyalev (foscarbidopa and foslevodopa) as the first and...
Darling Ingredients Announces Publication of Peer-Reviewed Collagen Peptides Study and its Impact on Post-Meal Blood Glucose Spikes
IRVING, Texas, Oct. 21, 2024. Darling Ingredients Inc. today announced the publication of preclinical and clinical studies1 in the Wiley Journal of Food...
Measures of Social Support Linked to Cancer Screening
Measures of social support are associated with screening for specific types of cancer, according to a study published online Oct. 18 in Cancer Causes &...
Study Characterizes Pediatric Patients Self-Presenting With Major Trauma
Pediatric patients self-presenting with injuries consistent with major trauma typically have external signs of injury, notably boggy swelling to the head,...
People With Inflammatory Bowel Disease Face Barriers to Health Care
Patients with inflammatory bowel disease (IBD) continue to experience barriers to health care access and treatment and financial struggles, according to...
Acupuncture Reduces Pain With Chronic Sciatica From Herniated Disk
Acupuncture results in less pain and better function for patients with chronic sciatica from a herniated disk, according to a study published online Oct....
U.S. Infant Deaths Rose After Fall of Roe v. Wade
The United States experienced a small but significant rise in infant deaths in the months following the U.S. Supreme Court's decision overturned Roe v....
Biden Proposes That Insurers Cover Over-the-Counter Birth Control
Health insurers would be required to cover the cost of over-the-counter birth control and emergency contraception under new rules proposed by the White...
Walking Pneumonia Cases Spike Among Young Kids
Walking pneumonia cases are surging among young children in the United States, federal health officials warn. "Bacterial infections caused by Mycoplasma...
Flesh-Eating Bacteria Cases Rise in Florida in Wake of Storms
Following the devastation of hurricanes Helene and Milton, a new health danger has emerged in Florida: A spike in cases of flesh-eating bacteria. In a statement issued...
Phase 2 study demonstrates the first successful clinical application of antifibrotic therapy for breast cancer
SAN DIEGO, Oct. 18, 2024. MeCo Diagnostics, a venture-backed startup dedicated to unlocking a new therapeutic modality for cancer, has announced a publication...
Public Safety Notification on Amniotic Fluid Eyedrops
October 17, 2024 Update: In August 2024, FDA received information from two consumers who reported adverse events such as shooting pain in the eyes after...
Silent Damage First: Alzheimer's Disease Could Have Two Phases
Alzheimer’s disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly and silently appears...
C&A Naturistics Issues Voluntary Nationwide Recall of AK Forte Tablets con Ortiga y Omega 3 Due to the Presence of Undeclared Drug Ingredients
October 16, 2024 – National City, CA, C&A Naturistics is voluntarily recalling all lots of AK Forte, 400 mg tablets, to the consumer level. FDA...
Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL Due to the Presence of Glass Particles
Bennet, NE -- STASKA PHARMACEUTICALS, INC. is voluntarily recalling 1 lot of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL,...
Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), today announced the submission of a New Drug Application (NDA) to the U.S. Food...
Recently Added
Recently added consumer and prescribing information: Imuldosa, Hympavzi, Flyrcado, Otulfi, Tecentriq Hybreza, Pavblu, Livdelzi, Yorvipath, Crexont, Lymphir
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Vyloy Vyloy (zolbetuximab-clzb) is a claudin 18.2-directed cytolytic antibody used for the combination treatment of patients with HER2-negative...
- Vyalev Vyalev (foscarbidopa and foslevodopa) is a carbidopa prodrug and levodopa prodrug combination indicated for the treatment of motor...
- Imuldosa Imuldosa (ustekinumab-srlf) is a human interleukin-12 and -23 antagonist biosimilar to Stelara used for the treatment of plaque psoriasis...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...